CASTLE BIOSCIENCES, INC. (CSTL) Net income 2018–2025
CASTLE BIOSCIENCES, INC. (CSTL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$24.2MFY2025 · since FY2018: -$6.4M → -$24.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.2M | -232.4% |
| FY2024 | $18.2M | +131.7% |
| FY2023 | -$57.5M | +14.4% |
| FY2022 | -$67.1M | -114.6% |
| FY2021 | -$31.3M | -204.3% |
| FY2020 | -$10.3M | -294.9% |
| FY2019 | $5.3M | +182.9% |
| FY2018 | -$6.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CSTL financial trends
CSTL RevenueCSTL Net marginCSTL Gross profitCSTL Gross marginCSTL Operating incomeCSTL Operating marginCSTL Operating cash flowCSTL Free cash flowCSTL Capital expendituresCSTL Return on equityCSTL Stock buybacksCSTL Dividends paidCSTL Total assetsCSTL Total liabilitiesCSTL Shareholders’ equityCSTL overview →